Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
- PMID: 1470917
- DOI: 10.1126/science.1470917
Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
Abstract
Vaccine protection against the human immunodeficiency virus (HIV) and the related simian immunodeficiency virus (SIV) in animal models is proving to be a difficult task. The difficulty is due in large part to the persistent, unrelenting nature of HIV and SIV infection once infection is initiated. SIV with a constructed deletion in the auxiliary gene nef replicates poorly in rhesus monkeys and appears to be nonpathogenic in this normally susceptible host. Rhesus monkeys vaccinated with live SIV deleted in nef were completely protected against challenge by intravenous inoculation of live, pathogenic SIV. Deletion of nef or of multiple genetic elements from HIV may provide the means for creating a safe, effective, live attenuated vaccine to protect against acquired immunodeficiency syndrome (AIDS).
Comment in
-
AIDS vaccines: is older better?Science. 1992 Dec 18;258(5090):1880-1. doi: 10.1126/science.1470911. Science. 1992. PMID: 1470911 No abstract available.
Similar articles
-
Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion.Immunol Lett. 1996 Jun;51(1-2):129-35. doi: 10.1016/0165-2478(96)02567-9. Immunol Lett. 1996. PMID: 8811357
-
Live attenuated SIV vaccines are not effective in a postexposure vaccination model.AIDS Res Hum Retroviruses. 1997 May 1;13(7):593-9. doi: 10.1089/aid.1997.13.593. AIDS Res Hum Retroviruses. 1997. PMID: 9135877 Clinical Trial.
-
Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.Virology. 1995 Oct 1;212(2):392-7. doi: 10.1006/viro.1995.1496. Virology. 1995. PMID: 7571408
-
Protective immunity induced by live attenuated simian immunodeficiency virus.Curr Opin Immunol. 1998 Aug;10(4):436-43. doi: 10.1016/s0952-7915(98)80118-0. Curr Opin Immunol. 1998. PMID: 9722920 Review.
-
Live attenuated AIDS viruses as vaccines: promise or peril?Immunol Rev. 1999 Aug;170:135-49. doi: 10.1111/j.1600-065x.1999.tb01335.x. Immunol Rev. 1999. PMID: 10566148 Review.
Cited by
-
Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.Viruses. 2012 Nov 14;4(11):3132-61. doi: 10.3390/v4113132. Viruses. 2012. PMID: 23202519 Free PMC article. Review.
-
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines.Nat Med. 2012 Nov;18(11):1673-81. doi: 10.1038/nm.2934. Epub 2012 Sep 9. Nat Med. 2012. PMID: 22961108 Free PMC article.
-
HIV-1 prophylactic vaccines: state of the art.J Virus Erad. 2016 Jan 1;2(1):5-11. doi: 10.1016/S2055-6640(20)30695-6. J Virus Erad. 2016. PMID: 27482428 Free PMC article. Review.
-
The KT Jeang Retrovirology prize 2016: Frank Kirchhoff.Retrovirology. 2016 Aug 5;13(1):53. doi: 10.1186/s12977-016-0286-5. Retrovirology. 2016. PMID: 27492506 Free PMC article. No abstract available.
-
Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.J Virol. 2020 Nov 23;94(24):e00979-20. doi: 10.1128/JVI.00979-20. Print 2020 Nov 23. J Virol. 2020. PMID: 33028714 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
